Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

N. Vogelzangs, H.E. Duivis, A.T.F. Beekman, C. Kluft, J. Neuteboom, W.J.G. Hoogendijk, J.H. Smit, P. de Jonge, B.W.J.H. Penninx

    Research output: Contribution to JournalArticleAcademicpeer-review

    173 Downloads (Pure)

    Abstract

    Growing evidence suggests that immune dysregulation may be involved in depressive disorders, but the exact nature of this association is still unknown and may be restricted to specific subgroups. This study examines the association between depressive disorders, depression characteristics and antidepressant medication with inflammation in a large cohort of controls and depressed persons, taking possible sex differences and important confounding factors into account. Persons (18-65 years) with a current (N=1132) or remitted (N=789) depressive disorder according to DSM-IV criteria and healthy controls (N=494) were selected from the Netherlands Study of Depression and Anxiety. Assessments included clinical characteristics (severity, duration and age of onset), use of antidepressant medication and inflammatory markers (C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α)). After adjustment for sociodemographics, currently depressed men, but not women, had higher levels of CRP (1.33 versus 0.92 mgl
    Original languageEnglish
    Article numbere79
    JournalTranslational Psychiatry
    Volume2
    DOIs
    Publication statusPublished - 2012

    Fingerprint Dive into the research topics of 'Association of depressive disorders, depression characteristics and antidepressant medication with inflammation'. Together they form a unique fingerprint.

    Cite this